Literature DB >> 20702522

Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals.

Carlos Lorenzo1, Steven M Haffner, Alena Stancáková, Markku Laakso.   

Abstract

CONTEXT: Methods to directly measure insulin resistance are invasive, complex, and costly. Surrogate indexes derived from the oral glucose tolerance test (OGTT) have been developed, but few studies have systematically analyzed these indexes.
OBJECTIVE: We examined the relation of surrogate and direct measures of insulin resistance to metabolic variables. DESIGN AND
SETTING: We conducted a cross-sectional analysis of the validation cohort of the Metabolic Syndrome in Men study. PARTICIPANTS: Participants included 272 nondiabetic Finnish offspring of type 2 diabetic individuals (age, 24-50 yr; 55% female). INTERVENTION: Surrogate indexes of insulin resistance were computed according to published formulas. Insulin sensitivity was also directly measured by the euglycemic-hyperinsulinemic clamp.
RESULTS: The strength of the correlation of the Matsuda index with directly measured insulin sensitivity (r = 0.77) was similar to that of Avignon's insulin sensitivity index (r = 0.76; P = 0.581) and simple index assessing insulin sensitivity using OGTT measurements (r = 0.74; P = 0.060) and stronger than that of indexes derived from fasting measurements [e.g. fasting insulin (r = 0.72; P = 0.011) and homeostasis model assessment of insulin resistance (r = 0.71; P = 0.001)]. Surrogate indexes were similar to directly measured insulin sensitivity in their relationships with metabolic abnormalities including definitive measures of fat distribution. Some indexes, however, had distinctive correlations: McAuley index with lipoproteins and Avignon insulin sensitivity and Stumvoll indexes with adiposity and fibrinogen.
CONCLUSIONS: Surrogate indexes are valid measures of insulin resistance. Multiple sampling times during an OGTT may not be mandatory to adequately estimate insulin resistance in clinical and epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702522     DOI: 10.1210/jc.2010-1144

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  48 in total

1.  Limitations in surrogate measures of insulin resistance.

Authors:  Thomas A Buchanan; Richard M Watanabe; Anny H Xiang
Journal:  J Clin Endocrinol Metab       Date:  2010-11       Impact factor: 5.958

2.  Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance.

Authors:  Mark O Goodarzi; Jinrui Cui; Yii-Der I Chen; Willa A Hsueh; Xiuqing Guo; Jerome I Rotter
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-31       Impact factor: 4.310

3.  Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Are there not some surrogate indexes lost in this story? Reply to Bastard JP, Rabasa-Lhoret R, Laville M and Disse E [letter].

Authors:  Julia Otten; Bo Ahrén; Tommy Olsson
Journal:  Diabetologia       Date:  2014-11-22       Impact factor: 10.122

4.  Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Are there not some surrogate indexes lost in this story?

Authors:  Jean-Philippe Bastard; Rémi Rabasa-Lhoret; Martine Laville; Emmanuel Disse
Journal:  Diabetologia       Date:  2014-10-24       Impact factor: 10.122

Review 5.  Effects of exercise training on mitochondrial function in patients with type 2 diabetes.

Authors:  Steen Larsen; Stinna Skaaby; Jørn W Helge; Flemming Dela
Journal:  World J Diabetes       Date:  2014-08-15

6.  Genetic support for the causal role of insulin in coronary heart disease.

Authors:  Emmi Tikkanen; Matti Pirinen; Antti-Pekka Sarin; Aki S Havulinna; Satu Männistö; Juha Saltevo; Marja-Liisa Lokki; Juha Sinisalo; Annamari Lundqvist; Antti Jula; Veikko Salomaa; Samuli Ripatti
Journal:  Diabetologia       Date:  2016-08-26       Impact factor: 10.122

7.  Effect of Metabolic Syndrome on Late-Life Depression: Associations with Disease Severity and Treatment Resistance.

Authors:  John S Mulvahill; Ginger E Nicol; David Dixon; Eric J Lenze; Jordan F Karp; Charles F Reynolds; Daniel M Blumberger; Benoit H Mulsant
Journal:  J Am Geriatr Soc       Date:  2017-12       Impact factor: 5.562

8.  Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study.

Authors:  Carla Giordano; Alessandro Ciresi; Marco Calogero Amato; Rosario Pivonello; Renata Simona Auriemma; Ludovica Francesca Stella Grasso; Aldo Galluzzo; Annamaria Colao
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

9.  Vitamin D status and insulin sensitivity are novel predictors of resting metabolic rate: a cross-sectional analysis in Australian adults.

Authors:  E K Calton; K Pathak; M J Soares; H Alfonso; K N Keane; P Newsholme; N K Cummings; W Chan She Ping-Delfos; A Hamidi
Journal:  Eur J Nutr       Date:  2015-08-26       Impact factor: 5.614

10.  Use of the DISST model to estimate the HOMA and Matsuda indexes using only a basal insulin assay.

Authors:  Shaun M Davidson; Paul D Docherty; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2014-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.